4 completed, 1 terminated, 1 unknown. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 1, Unknown 1 |
Follow Post-COVID-19 Syndrome: new trials by email Literature Review of Post-COVID-19 Syndrome trials Research Report on Post-COVID-19 Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS) Methylprednisolone - Post-COVID-19 Syndrome | Phase 2 | Terminated | Charite University, Berlin, Germany | 96 | 2023-10-01 | 2026-05-05 |
| ImPROving Quality of LIFe in the Long COVID Patient Nirmatrelvir/ritonavir, Placebo/ritonavir - Post-COVID-19 Syndrome, Long COVID | Phase 2 | Completed | Karolinska Institutet | 219 | 2023-05-01 | 2024-12-04 |
| The Effect of Amantadine on Post-COVD-19 Fatigue Amantadine - Post-COVID-19 Syndrome | Phase 2 | Unknown | Shahid Beheshti University of Medical Sciences | 83 | 2022-12-26 | 2022-12-28 |
| Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome Temelimab 54mg/kg, Placebo - Post-COVID-19 Syndrome | Phase 2 | Completed | GeNeuro SA | 203 | 2022-08-29 | 2024-05-17 |
| Vortioxetine for Post-COVID-19 Condition Vortioxetine, Placebo - Post-COVID-19 Condition, Post-COVID-19 Syndrome | Phase 2 | Completed | Brain and Cognition Discovery Foundation | 149 | 2021-09-16 | 2025-01-16 |
| Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome Naltrexone, NAD+ - Covid19, Long COVID-19 | Phase 2 | Completed | AgelessRx | 36 | 2021-01-28 | 2023-01-25 |
Post-Acute COVID-19 Syndrome (6) · COVID-19 (2) · Cognition Disorders (2) · Cognitive Dysfunction (1) · Fatigue (1) · Mental Fatigue (1) · Post-Infectious Disorders (1) · Postural Orthostatic Tachycardia Syndrome (1)
Chronic Disease (6) · Coronaviridae Infections (6) · Coronavirus Infections (6) · Disease Attributes (6) · Infections (6) · Lung Diseases (6) · Nidovirales Infections (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Pneumonia (6) · Pneumonia, Viral (6) · RNA Virus Infections (6) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6) · Virus Diseases (6)
Amantadine (1) · Methylprednisolone (1) · NAD (1) · Naltrexone (1) · Ritonavir (1) · Vortioxetine (1) · nirmatrelvir and ritonavir drug combination (1) · temelimab (1)
AgelessRx (1) · Brain and Cognition Discovery Foundation (1) · Charite University, Berlin, Germany (1) · GeNeuro SA (1) · Karolinska Institutet (1) · Shahid Beheshti University of Medical Sciences (1)
Canada (1) · Germany (1) · Iran (1) · Italy (1) · Spain (1) · Sweden (1) · Switzerland (1) · United States (1)
Heinrich Audebert, Prof., MD (1) · Michael Runold, MD, PhD (1) · Roger S. McIntyre, MD, FRCPC (1) · Sajad Zalzala, MD (1)
PMID 38114867, PMID 38424537, PMID 38520501, PMID 38860901, PMID 38954402, PMID 42409185